Ventricular Function and Tissue Characterization By Cardiac MRI in Children Following Hospitalization for Multisystem

Michael P Dilorenzo1, Kanwal M Farooqi1, Amee M Shah1

  • 1CUIMC: Columbia University Irving Medical Center.

Research Square
|February 4, 2022
PubMed

Insights

Children with Multisystem Inflammatory Syndrome (MIS-C) show excellent cardiac recovery after acute illness. Cardiac MRI at 6-9 months reveals minimal residual myocardial involvement, suggesting good long-term heart health post-MIS-C.

Area of Science:

  • Pediatrics
  • Cardiology
  • Infectious Diseases

Background:

  • Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe complication of SARS-CoV-2 infection, often presenting with acute cardiac dysfunction.
  • The long-term effects of MIS-C on myocardial function and structure remain largely unknown.
  • Understanding residual cardiac impact is crucial for managing pediatric patients post-MIS-C.

Approach:

  • A prospective study utilized cardiac MRI (CMR) to assess myocardial status in pediatric patients (aged <21) 6-9 months post-MIS-C hospitalization.
  • CMR included T1/T2 mapping and late gadolinium enhancement (LGE) to evaluate for edema, inflammation, and fibrosis.
  • Patients with prior LVEF <50%, persistent symptoms, or ECG abnormalities underwent clinical CMR; others over 10 years received research CMRs.

Key Points:

  • CMRs were performed on 13 MIS-C patients at a median of 8.2 months post-hospitalization.
  • Twelve subjects exhibited normal ventricular function (LVEF median 57.2%, RV EF median 53.1%).
  • Native T1/T2 mapping and T2-weighted imaging showed no significant differences compared to healthy controls; one patient had LGE without functional impairment.

Conclusions:

  • Children with MIS-C demonstrate excellent myocardial recovery, with minimal evidence of residual cardiac dysfunction or inflammation 6-9 months after acute illness.
  • While LVEF was slightly lower in those with prior echocardiographic LV dysfunction, it remained within normal CMR ranges.
  • Further research is warranted to fully elucidate the long-term cardiac implications of MIS-C.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
38
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
153
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
42
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
79